Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial

1. Mateos, M.-V.
2. Hernández, M.-T.
3. Giraldo, P.
4. de la Rubia, J.
5. de Arriba, F.
6. Corral, L.L.
7. Rosiñol, L.
8. Paiva, B.
9. Palomera, L.
10. Bargay, J.
11. Oriol, A.
12. Prosper, F.
13. López, J.
14. Arguiñano, J.-M.
15. Quintana, N.
16. García, J.-L.
17. Bladé, J.
18. Lahuerta, J.-J.
19. Miguel, J.-F.S.